Pan Tumor Study – Effectively Treatment for HER2-Expressing Cancers Regardless of Tumor Location

Trastuzumab deruxtecan (Enhertu®) is an effective treatment option for patients with difficult-to-treat HER2-expressing solid tumors, according to these findings from an international study uncovering effectiveness across tumor locations.